Xponance Inc. Has $4.09 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Xponance Inc. lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,897 shares of the company’s stock after selling 177 shares during the quarter. Xponance Inc.’s holdings in GE HealthCare Technologies were worth $4,090,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of GEHC. First Command Advisory Services Inc. increased its position in shares of GE HealthCare Technologies by 36,900.0% in the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock worth $25,000 after acquiring an additional 369 shares in the last quarter. Pin Oak Investment Advisors Inc. purchased a new position in GE HealthCare Technologies during the 2nd quarter worth approximately $25,000. Legacy Financial Group LLC acquired a new stake in GE HealthCare Technologies during the 3rd quarter valued at $26,000. OFI Invest Asset Management purchased a new stake in shares of GE HealthCare Technologies in the third quarter valued at $26,000. Finally, Resources Management Corp CT ADV acquired a new stake in shares of GE HealthCare Technologies in the second quarter worth $28,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 0.6 %

GEHC stock opened at $84.49 on Friday. The firm has a market cap of $38.56 billion, a PE ratio of 27.98, a PEG ratio of 2.94 and a beta of 0.94. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50. The company has a fifty day simple moving average of $88.74 and a 200 day simple moving average of $77.89. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business’s revenue was up 5.3% compared to the same quarter last year. During the same period last year, the company earned $1.31 earnings per share. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.97%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Argus increased their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. Morgan Stanley raised their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. Citigroup upped their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their target price for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Finally, Evercore ISI upped their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.